CRISPR

CRISPR2-cryabb

ID
ZDB-CRISPR-180521-6
Name
CRISPR2-cryabb
Previous Names
  • T02 (1)
Target
Sequence
5' - CTCCCCAAATTGCCGGCG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
vu613 cryabb
Expression
Gene expression in Wild Types + CRISPR2-cryabb
No data available
Phenotype
Phenotype resulting from CRISPR2-cryabb
No data available
Phenotype of all Fish created by or utilizing CRISPR2-cryabb
Phenotype Fish Conditions Figures
pericardium edematous, abnormal cryabbvu613/vu613 (AB) chemical treatment by environment: cortisol Fig. 5 from Mishra et al., 2018
heart contraction process quality, abnormal cryabbvu613/vu613 (AB) chemical treatment by environment: dexamethasone Fig. 5 from Mishra et al., 2018
heart contraction decreased rate, abnormal cryabbvu613/vu613 (AB) chemical treatment by environment: dexamethasone Fig. 5 from Mishra et al., 2018
lens morphology, exacerbated cryabbvu613/vu613 (AB) stress Fig. 4 from Mishra et al., 2018
heart contraction decreased rate, abnormal cryabbvu613/vu613 (AB) control Fig. 5 from Mishra et al., 2018
pericardium edematous, abnormal cryabbvu613/vu613 (AB) stress Fig. 4 from Mishra et al., 2018
cardiac ventricle dilated, abnormal cryabbvu613/vu613 (AB) chemical treatment by environment: dexamethasone Fig. 5 from Mishra et al., 2018
lens morphology, abnormal cryabbvu613/vu613 (AB) control Fig. 3Fig. 4Fig. 6 from Mishra et al., 2018
pericardium edematous, abnormal cryabbvu613/vu613 (AB) chemical treatment by environment: dexamethasone Fig. 5 from Mishra et al., 2018
atrium dilated, abnormal cryabbvu613/vu613 (AB) chemical treatment by environment: dexamethasone Fig. 5 from Mishra et al., 2018
pericardium edematous, abnormal cryabavu612/vu612; cryabbvu613/vu613 (AB) chemical treatment by environment: cortisol Fig. 5 from Mishra et al., 2018
pericardium edematous, abnormal cryabavu612/vu612; cryabbvu613/vu613 (AB) chemical treatment by environment: dexamethasone Fig. 5 from Mishra et al., 2018
lens morphology, abnormal cryabavu612/vu612; cryabbvu613/vu613 (AB) control Fig. 3 from Mishra et al., 2018
lens morphology, ameliorated cryabbvu613/vu613; vu614Tg control Fig. 6 from Mishra et al., 2018
lens morphology, exacerbated cryabavu612/vu612; cryabbvu613/vu613; vu617Tg control Fig. 5 from Wu et al., 2018
Citations